Moderna, Inc. (FRA:0QF)

Market Cap	16.72B +29.4%
Revenue (ttm)	1.66B -39.9%
Net Income	-2.40B
EPS	-6.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	682
Average Volume	1,525
Open	42.07
Previous Close	42.20
Day's Range	41.47 - 42.10
52-Week Range	19.26 - 46.96
Beta	n/a
RSI	62.73
Earnings Date	Feb 13, 2026

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2010
• Employees: 5,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0QF

Financial Performance

In 2025, Moderna's revenue was $1.94 billion, a decrease of -39.93% compared to the previous year's $3.24 billion. Losses were -$2.82 billion, -20.75% less than in 2024.

Financial numbers in USD